Michael A. Metzger
2020
In 2020, Michael A. Metzger earned a total compensation of $1.9M as Chief Operating Officer at Syndax Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $273,980 |
|---|---|
| Option Awards | $1,092,751 |
| Salary | $576,800 |
| Other | $6,000 |
| Total | $1,949,531 |
Metzger received $1.1M in option awards, accounting for 56% of the total pay in 2020.
Metzger also received $274K in non-equity incentive plan, $576.8K in salary and $6K in other compensation.
Rankings
In 2020, Michael A. Metzger's compensation ranked 5,636th out of 13,090 executives tracked by ExecPay. In other words, Metzger earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,636 out of 13,090 | 57th |
Division Manufacturing | 2,326 out of 5,620 | 59th |
Major group Chemicals And Allied Products | 928 out of 2,253 | 59th |
Industry group Drugs | 802 out of 1,953 | 59th |
Industry Pharmaceutical Preparations | 596 out of 1,458 | 59th |
Source: SEC filing on April 1, 2021.
Metzger's colleagues
We found two more compensation records of executives who worked with Michael A. Metzger at Syndax Pharmaceuticals in 2020.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019